The Manufacturers Life Insurance Company Grows Position in Humana Inc. $HUM

The Manufacturers Life Insurance Company increased its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 10.5% in the second quarter, Holdings Channel reports. The firm owned 70,185 shares of the insurance provider’s stock after buying an additional 6,690 shares during the period. The Manufacturers Life Insurance Company’s holdings in Humana were worth $27,879,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of HUM. Johnson Financial Group Inc. purchased a new position in Humana during the second quarter worth about $26,000. Trust Co. of Vermont acquired a new stake in shares of Humana during the second quarter valued at about $28,000. Bogart Wealth LLC raised its stake in shares of Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 48 shares during the period. MidFirst Bank purchased a new stake in shares of Humana in the 2nd quarter valued at approximately $35,000. Finally, Fideuram Asset Management Ireland dac acquired a new position in shares of Humana in the 4th quarter worth approximately $27,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently weighed in on HUM. Royal Bank Of Canada increased their price objective on shares of Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Oppenheimer restated an “outperform” rating and set a $405.00 price target on shares of Humana in a research note on Thursday, July 30th. Robert W. Baird set a $390.00 price target on Humana in a research report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft initiated coverage on Humana in a research report on Thursday, July 30th. They set a “hold” rating for the company. Finally, Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $227.00 to $502.00 in a report on Monday, July 13th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $403.91.

Get Our Latest Stock Report on HUM

Humana Trading Up 2.0%

Shares of HUM stock opened at $408.79 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a market capitalization of $49.09 billion, a P/E ratio of 38.67, a price-to-earnings-growth ratio of 2.53 and a beta of 0.74. The company has a 50 day moving average price of $388.94 and a 200 day moving average price of $303.54. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88.

Humana (NYSE:HUMGet Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same period in the prior year, the firm earned $6.27 EPS. Equities research analysts predict that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s dividend payout ratio is currently 33.49%.

Humana Company Profile

(Free Report)

Humana Inc (NYSE:HUM) is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.